Concepedia

Stephen C. Alley

SC

Statistics

Publications

48

Citations

4.8K

H-Index

34

Active since

1994

Affiliations

Seagen (United States)(Current)

Pennsylvania State University

University of Washington

United States Food and Drug Administration

Bristol-Myers Squibb (United States)

Stephen C. Alley is an author at Seagen (United States) specializing in medicine, natural sciences, and biochemistry.

Top concepts

Publications per year

1994–2022

48

Publications

48

Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery:  Effects of Linker Technology on Efficacy and Toxicity

Svetlana O. Doronina, Brian A. Mendelsohn, Tim D. Bovee et al. · Bioconjugate Chemistry · 2005 · 506 citations

, , +19

Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates

Stephen C. Alley, Dennis R. Benjamin, Scott C. Jeffrey et al. · Bioconjugate Chemistry · 2008 · 456 citations

, , +18

Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate

Nicole M. Okeley, Jamie B. Miyamoto, Xinqun Zhang et al. · Clinical Cancer Research · 2010 · 381 citations · Full text

Recruitment of HAT Complexes by Direct Activator Interactions with the ATM-Related Tra1 Subunit

Christine E. Brown, LeAnn J. Howe, Kyle M. Sousa et al. · Science · 2001 · 368 citations

Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody Disulfides

Michael Sun, Kevin S. Beam, Charles G. Cerveny et al. · Bioconjugate Chemistry · 2005 · 359 citations · Full text

Rows per page

1–5 of 48